Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
- PMID: 29512598
- PMCID: PMC5861467
- DOI: 10.4103/ijmr.IJMR_1354_17
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
Abstract
Breast cancer is a heterogeneous disease and may present with different clinical and biological characteristics. At present, breast cancer is divided into molecular subgroups besides its histopathological classification. Decision for adjuvant chemotherapy is made based on not only histopathological characteristics but also molecular and genomic characteristics using indices, guidelines and calculators in early-stage breast cancer. Making a treatment plan through all these prognostic and predictive methods according to risk categories aims at preventing unnecessary or useless treatments. In this review, an attempt to make a general assessment of prognostic and predictive methods is made which may be used for planning individualized therapy and also the comments of the guidelines used by the oncologists worldwide on these methods.
Keywords: Adjuvant chemotherapy - early-stage breast cancer - predictive - prognostic.
Conflict of interest statement
None.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Lyon. France: International Agency for Research on Cancer; 2013.
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Nagao T, Kinoshita T, Hojo T, Tsuda H, Tamura K, Fujiwara Y, et al. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: The relationship between the outcome and the clinicopathological characteristics. Breast. 2012;21:289–95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous